Shamburg News · 8-K filed Oct 20, 2026, 8:00 AM EDT
PDS Biotechnology Board Accepts Four Resignations and Appoints Three New Directors
PDSB · PDS Biotechnology Corp
- Leadership change
- Other event
- Materiality: medium
On October 18, 2026, directors Kamil Ali-Jackson, Stephen Glover, Gregory Freitag and Otis Brawley resigned from the Board and its committees, effective immediately, with no disagreement reported. The Board appointed Deborah A. Ramsdell, John A. Dawson CBE and Bruce Wendel as directors on the same date to fill three of the four vacancies, fixing the Board at seven directors. Each new director received a nonqualified stock option for 22,700 shares, and the Board reconstituted its Audit, Compensation and Nominating committees, as announced in an October 20, 2026 press release.
Source: SEC EDGAR, Form 8-K, Items 5.02, 8.01, 9.01, accession 0001140361-26-040181.
Written from the filing by Shamburg Markets. Figures are as reported by the company.